These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 25613699)
1. PTEN and hTERT gene expression and the correlation with human hepatocellular carcinoma. Zhou X; Zhu H; Lu J Pathol Res Pract; 2015 Apr; 211(4):316-9. PubMed ID: 25613699 [TBL] [Abstract][Full Text] [Related]
2. Expression and significance of PTEN and miR-92 in hepatocellular carcinoma. Zhao B; Zhu Y; Cui K; Gao J; Yu F; Chen L; Li S Mol Med Rep; 2013 May; 7(5):1413-6. PubMed ID: 23546593 [TBL] [Abstract][Full Text] [Related]
3. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma. El-Mazny A; Sayed M; Sharaf S Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049 [TBL] [Abstract][Full Text] [Related]
4. Dedifferentiation of human hepatocellular carcinoma up-regulates telomerase and Ki-67 expression. Yeh TS; Chen TC; Chen MF Arch Surg; 2000 Nov; 135(11):1334-9. PubMed ID: 11074892 [TBL] [Abstract][Full Text] [Related]
6. [Expression of telomerase reverse transcriptase and its relationship with tumor suppressor gene p53 in HCC]. Dai D; Zhai W; Zhu T; Zhu H; Ling Y Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():79-81. PubMed ID: 11509149 [TBL] [Abstract][Full Text] [Related]
7. [Expression of human telomerase reverse transcriptase gene in HCC does not depend on proliferating cell nuclear antigen and P53]. Zhang D; Li KZ; Dou KF; Gao ZQ; Song ZS; Zhao QC; Fu YC Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):721-2. PubMed ID: 15555445 [TBL] [Abstract][Full Text] [Related]
8. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma. Toshikuni N; Nouso K; Higashi T; Nakatsukasa H; Onishi T; Kaneyoshi T; Kobayashi Y; Kariyama K; Yamamoto K; Tsuji T Br J Cancer; 2000 Feb; 82(4):833-7. PubMed ID: 10732755 [TBL] [Abstract][Full Text] [Related]
9. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485 [TBL] [Abstract][Full Text] [Related]
10. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression. Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT. Luan F; Liu H; Gao L; Liu J; Sun Z; Ju Y; Hou N; Guo C; Liang X; Zhang L; Sun W; Ma C Gut; 2009 Nov; 58(11):1528-37. PubMed ID: 19651630 [TBL] [Abstract][Full Text] [Related]
12. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase. Stefanou N; Papanikolaou V; Furukawa Y; Nakamura Y; Tsezou A BMC Cancer; 2010 Aug; 10():442. PubMed ID: 20723213 [TBL] [Abstract][Full Text] [Related]
13. Telomerase and c-myc expression in hepatocellular carcinomas. Liu YC; Chen CJ; Wu HS; Chan DC; Yu JC; Yang AH; Cheng YL; Lee SC; Harn HJ Eur J Surg Oncol; 2004 May; 30(4):384-90. PubMed ID: 15063891 [TBL] [Abstract][Full Text] [Related]
14. Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma. Nagao K; Tomimatsu M; Endo H; Hisatomi H; Hikiji K J Gastroenterol; 1999 Feb; 34(1):83-7. PubMed ID: 10204615 [TBL] [Abstract][Full Text] [Related]
15. Levels of telomerase catalytic subunit mRNA as a predictor of potential malignancy. Hisatomi H; Nagao K; Kanamaru T; Endo H; Tomimatsu M; Hikiji K Int J Oncol; 1999 Apr; 14(4):727-32. PubMed ID: 10087321 [TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis. Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581 [TBL] [Abstract][Full Text] [Related]
17. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis. Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643 [TBL] [Abstract][Full Text] [Related]
18. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma. Sitaram RT; Cairney CJ; Grabowski P; Keith WN; Hallberg B; Ljungberg B; Roos G Int J Cancer; 2009 Aug; 125(4):783-90. PubMed ID: 19384955 [TBL] [Abstract][Full Text] [Related]
19. Oxidative stress may enhance the malignant potential of human hepatocellular carcinoma by telomerase activation. Nishikawa T; Nakajima T; Katagishi T; Okada Y; Jo M; Kagawa K; Okanoue T; Itoh Y; Yoshikawa T Liver Int; 2009 Jul; 29(6):846-56. PubMed ID: 19141026 [TBL] [Abstract][Full Text] [Related]
20. [PTEN expression and its significance in human primary hepatocellular carcinoma]. Wan XW; Wang HY; Jiang M; He YQ; Liu SQ; Cao HF; Qiu XH; Tang L; Wu MC Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):490-2. PubMed ID: 12939185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]